ebook Munafa Stock Market Course + Intraday & FNO calls  

       

InnatePharma IPHA full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

Innate Pharma IPHA WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange

Daily price and charts and targets InnatePharma

Strong intraday Stock price targets for InnatePharma are 1.63 and 1.74

Intraday Target 11.55
Intraday Target 21.6
Intraday Target 31.6566666666667
Intraday Target 41.71
Intraday Target 51.77

Daily price and volume Innate Pharma

Date Closing Open Range Volume
Fri 17 April 2026 1.66 (2.47%) 1.61 1.60 - 1.71 1.3395 times
Thu 16 April 2026 1.62 (-4.14%) 1.69 1.62 - 1.72 1.4352 times
Wed 15 April 2026 1.69 (3.68%) 1.73 1.64 - 1.75 0.3077 times
Tue 14 April 2026 1.63 (13.19%) 1.53 1.53 - 1.71 1.6964 times
Mon 13 April 2026 1.44 (2.13%) 1.39 1.38 - 1.48 0.3465 times
Fri 10 April 2026 1.41 (-2.76%) 1.42 1.41 - 1.45 1.1973 times
Thu 09 April 2026 1.45 (0%) 1.44 1.42 - 1.45 1.5775 times
Wed 08 April 2026 1.45 (7.41%) 1.49 1.41 - 1.50 0.5224 times
Tue 07 April 2026 1.35 (-2.88%) 1.36 1.32 - 1.37 1.0473 times
Mon 06 April 2026 1.39 (1.46%) 1.46 1.39 - 1.46 0.5301 times
Thu 02 April 2026 1.37 (1.48%) 1.33 1.33 - 1.40 0.4448 times

 Daily chart InnatePharma

Weekly price and charts InnatePharma

Strong weekly Stock price targets for InnatePharma IPHA are 1.52 and 1.89

Weekly Target 11.23
Weekly Target 21.44
Weekly Target 31.5966666666667
Weekly Target 41.81
Weekly Target 51.97

Weekly price and volumes for Innate Pharma

Date Closing Open Range Volume
Fri 17 April 2026 1.66 (17.73%) 1.39 1.38 - 1.75 1.9571 times
Fri 10 April 2026 1.41 (2.92%) 1.46 1.32 - 1.50 1.8613 times
Thu 02 April 2026 1.37 (5.38%) 1.26 1.25 - 1.40 0.5638 times
Fri 27 March 2026 1.30 (11.11%) 1.29 1.21 - 1.44 1.7161 times
Fri 20 March 2026 1.17 (-22%) 1.42 1.17 - 1.47 0.8316 times
Fri 13 March 2026 1.50 (-6.25%) 1.60 1.40 - 1.65 1.2759 times
Fri 06 March 2026 1.60 (-6.98%) 1.62 1.58 - 1.71 0.1481 times
Fri 27 February 2026 1.72 (6.17%) 1.62 1.62 - 1.80 0.4661 times
Fri 20 February 2026 1.62 (-6.9%) 1.74 1.57 - 1.77 0.9153 times
Fri 13 February 2026 1.74 (0%) 1.71 1.71 - 1.86 0.2646 times
Fri 13 February 2026 1.74 (1.75%) 1.74 1.66 - 1.86 1.7892 times

 weekly chart InnatePharma

Monthly price and charts InnatePharma

Strong monthly Stock price targets for InnatePharma IPHA are 1.49 and 1.92

Monthly Target 11.15
Monthly Target 21.4
Monthly Target 31.5766666666667
Monthly Target 41.83
Monthly Target 52.01

Monthly price and volumes Innate Pharma

Date Closing Open Range Volume
Fri 17 April 2026 1.66 (29.69%) 1.33 1.32 - 1.75 0.2803 times
Tue 31 March 2026 1.28 (-25.58%) 1.62 1.17 - 1.71 0.29 times
Fri 27 February 2026 1.72 (-6.01%) 1.87 1.57 - 1.87 0.2533 times
Fri 30 January 2026 1.83 (4.57%) 1.82 1.70 - 1.89 0.2735 times
Wed 31 December 2025 1.75 (-10.26%) 1.93 1.63 - 2.01 0.4024 times
Fri 28 November 2025 1.95 (-1.02%) 1.88 1.73 - 2.43 7.5517 times
Fri 31 October 2025 1.97 (2.07%) 1.97 1.95 - 2.40 0.3775 times
Tue 30 September 2025 1.93 (-10.65%) 2.08 1.77 - 2.19 0.2968 times
Fri 29 August 2025 2.16 (2.37%) 2.22 1.97 - 2.40 0.0907 times
Thu 31 July 2025 2.11 (15.93%) 1.77 1.70 - 2.63 0.1839 times
Mon 30 June 2025 1.82 (-16.89%) 2.14 1.71 - 2.21 0.1238 times

 monthly chart InnatePharma

Yearly price and charts InnatePharma

Strong yearly Stock price targets for InnatePharma IPHA are 1.06 and 1.78

Yearly Target 10.85
Yearly Target 21.26
Yearly Target 31.5733333333333
Yearly Target 41.98
Yearly Target 52.29

Yearly price and volumes Innate Pharma

Date Closing Open Range Volume
Fri 17 April 2026 1.66 (-5.14%) 1.82 1.17 - 1.89 0.0462 times
Wed 31 December 2025 1.75 (-4.89%) 1.94 1.60 - 2.63 0.8287 times
Tue 31 December 2024 1.84 (-34.29%) 2.78 1.29 - 3.51 0.8942 times
Fri 29 December 2023 2.80 (-24.93%) 3.42 1.81 - 3.97 0.1195 times
Fri 30 December 2022 3.73 (-18.2%) 4.80 1.90 - 4.87 0.2685 times
Fri 31 December 2021 4.56 (11.49%) 4.23 3.02 - 11.95 5.6286 times
Thu 31 December 2020 4.09 (-36.49%) 8.24 3.30 - 8.24 0.1373 times
Tue 31 December 2019 6.44 (0%) 5.61 5.61 - 6.75 0.0769 times
Sat 18 April 2026 (0%) - 0 times

Indicator Analysis of InnatePharma

Tomorrow's movement Prediction of Innate Pharma IPHA appears to be in uptrend. And this trend seems to be continuing further.

Price is above an important level of 1.52 on charts, and as long as price remains above this level, the uptrend of stock might continue.

Tomorrow's movement Prediction of Innate Pharma IPHA made a major fall in previous days. This happens when sentiment changes towards negative. This fall might deepen in coming days.

Tomorrow's movement Prediction of Innate Pharma IPHA appears strongly Bullish. This stock started moving upwards as soon as it opened. Generally this happens when there is a positive sentiment following the stock, making it attractive. There's a good chance that this upwards movement will continue tomorrow as well.

Tomorrow's movement Prediction of Innate Pharma IPHA is bullish. The stock is trading above weekly resistance and downside can only be expected once it trades below 1.46

Munafa value: 90 as on Fri 17 April 2026

This Munafa value indicates that the stock is moving upwards and might continue to move up.

SMA20 is at 2 and price is deviating by 1 points

Upper Bollinger band is at 2 and lower is at 2, while middle bands are at 2 and 2

Price is rising

Price is above 20day SMA

Price is in upper range of bands

Price action analysis of InnatePharma (IPHA) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for InnatePharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for InnatePharma in short term and the buy signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

InnatePharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

CCI has generated a buy signal for InnatePharma in short term and BUY signal is strong.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of InnatePharma is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 1.52 and InnatePharma IPHA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the InnatePharma IPHA stock. Volume based technical analysis of InnatePharma IPHA stock is negative.

InnatePharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

DMA SMA EMA moving averages of Innate Pharma IPHA

DMA (daily moving average) of Innate Pharma IPHA

DMA period DMA value
5 day DMA 1.61
12 day DMA 1.48
20 day DMA 1.4
35 day DMA 1.47
50 day DMA 1.54
100 day DMA 1.68
150 day DMA 1.78
200 day DMA 1.84

EMA (exponential moving average) of Innate Pharma IPHA

EMA period EMA current EMA prev EMA prev2
5 day EMA1.61.571.55
12 day EMA1.521.491.47
20 day EMA1.491.471.45
35 day EMA1.521.511.5
50 day EMA1.571.571.57

SMA (simple moving average) of Innate Pharma IPHA

SMA period SMA current SMA prev SMA prev2
5 day SMA1.611.561.52
12 day SMA1.481.451.42
20 day SMA1.41.381.37
35 day SMA1.471.471.47
50 day SMA1.541.541.55
100 day SMA1.681.681.68
150 day SMA1.781.781.78
200 day SMA1.841.841.84

Videos related to: InnatePharma IPHA full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

Hindi Video What Is Needed To Succeed In Stock Markets

InnatePharma IPHA full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

 

Back to top